Mikolaj Zmudzinski

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Combination Therapy

Respiratory Syndrome Coronavirus

Molecular Docking

Top Venues

ACS central science

Nature chemical biology

Science advances

Chemical science

This page only lists publications with an associated author ORCID identifier.

Publications

Sizhu Amelia Chen, Elena Arutyunova, Jimmy Lu, Muhammad Bashir Khan, Wioletta Rut, Mikolaj Zmudzinski, Shima Shahbaz, Jegan Iyyathurai, Eman W Moussa, Zoe Turner, Bing Bai, Tess Lamer, James A Nieman, John C Vederas, Olivier Julien, Marcin Dra G, Shokrollah Elahi, Howard S Young, Mary Joanne Lemieux
SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. ACS central science 9 (4) (2023)
Sizhu Amelia Chen, Elena Arutyunova, Jimmy Lu, Muhammad Bashir Khan, Wioletta Rut, Mikolaj Zmudzinski, Shima Shahbaz, Jegan Iyyathurai, Eman W Moussa, Zoe Turner, Bing Bai, Tess Lamer, James A Nieman, John C Vederas, Olivier Julien, Marcin Dra G, Shokrollah Elahi, Howard S Young, Mary Joanne Lemieux
SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. ACS central science 9 (4) (2023)
Agata P Perlinska, Adam Stasiulewicz, Mai Lan Nguyen, Karolina W Swiderska, Mikolaj Zmudzinski, Alicja W Maksymiuk, Marcin Dra G, Joanna Ida Sulkowska
Amino acid variants of SARS-CoV-2 papain-like protease have impact on drug binding. PLoS computational biology 18 (11) (2022)
Izabela Nawrot-Hadzik, Mikolaj Zmudzinski, Adam Matkowski, Robert Preissner, Małgorzata Kęsik-Brodacka, Jakub Hadzik, Marcin Dra G, Renata Abel
Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors-Molecular Docking and In Vitro Study. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Wioletta Rut, Mikolaj Zmudzinski, Scott J Snipas, Miklos Bekes, Tony T Huang, Marcin Dra G
Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes. Chemical science 11 (23) (2020)
Wioletta Rut, Zongyang Lv, Mikolaj Zmudzinski, Stephanie Patchett, Digant Nayak, Scott J Snipas, Farid El Oualid, Tony T Huang, Miklós Békés, Marcin Dra G, Shaun K Olsen
Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design. Science advances 6 (42) (2020)
Wioletta Rut, Katarzyna Groborz, Linlin Zhang, Xinyuanyuan Sun, Mikolaj Zmudzinski, Bartłomiej Pawlik, Xinyu Wang, Dirk Jochmans, Johan Neyts, Wojciech Mlynarski, Rolf Hilgenfeld, Marcin Dra G
SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging. Nature chemical biology 17 (2) (2020)